▲ 3 r/FX3

need one more camera

We need a new camera but no rush but would be nice to have it sooner. we have a fx6 and fx3 and need one more should I get the fx3 or wait for the fx5. or be a cheap ass and get the fx30.

reddit.com
u/JustBacWater — 9 days ago

What made you stop looking at a compound you were originally interested in?

Everyone talks about what they added. Less gets said about what came off the list.

Sometimes it is the evidence. You go looking for the human data and find three mouse studies and a forum post. Sometimes it is the opposite, the data is fine but the practical side does not work. Sometimes a better option in the same category showed up and the first one just became redundant.

I am interested in the reasoning more than the compound.

What was it for you, and what actually tipped it? Was it something you read, something you noticed, or just the realization that it was not doing what the writeups said it would?

reddit.com
u/JustBacWater — 10 days ago

Peptide Epitalon passed the FDA panel 7 to 4, but most of the human data belongs to Epithalamin

Epitalon was one of the six that got a yes from the FDA panel in July, 7 to 4. A few of you asked what the panel was even looking at, and it brought me back to something a member here pointed out in the comments a while ago. They were right, and it's worth a full post.

There are two different things with almost the same name.

Epithalamin Epitalon
What it is A peptide extract from bovine pineal glands A synthetic peptide, four amino acids (AEDG)
Clean molecule? No, it's a mix Yes, purified
Where it came from Khavinson's group in St. Petersburg, 1970s Modeled on what they found in the extract
Human outcome trials Yes, the Kiev mortality studies None published
Where most of its research sits Russian clinical work Cell culture and animals

That last row is the whole post.

Why that matters

The human studies everybody quotes are Epithalamin studies.

The big one followed elderly heart patients in Kiev for 12 years. The group that got courses of epithalamin had 28% fewer deaths than the control group and half the cardiovascular deaths. There's a 15-year follow-up out of the same program with 39 treated patients and 40 controls.

Those are real published trials. They're also the extract.

The synthetic peptide's own published work is mostly cell culture and animals. Gene expression in human stem cells. Pineal and thymus cells aging in a dish. Mouse eggs in a culture medium. Interesting stuff, and the mechanism work is legit. It's just not a human trial.

When somebody says "Epitalon cut mortality 28%," that's not what the paper says. The paper says Epithalamin did, in one research group's trial, in a pretty specific population of older heart patients.

Where it gets messy

The protocols floating around for Epitalon trace back to the extract too. An extract is a crude mix where only part of it is the active piece. The synthetic is purified. Carrying numbers straight from one to the other doesn't make a lot of sense, and nobody has run the human trial that would tell you what the right answer is.

I've also seen claims that it cut mortality four times over. I can't find that number in the published trials. What's in the papers is the 28% and the 2x on cardiovascular deaths. If somebody has the paper with the bigger number, post it, because I want to read it.

What that means for the vote

The panel said yes anyway. Maybe they weighed the extract data. Maybe the long Russian clinical history. Maybe the safety record. I don't know what was in their heads.

But if you're reading that 7 to 4 as "the human evidence on Epitalon is solid," you're reading something that isn't there. The mechanism research is real. The human outcome data is for a cousin.

Two questions.

Did you know these were two separate substances before this?

And does it change how you read the vote, or do you think the extract data should carry over?

Where I got this: 12-year epithalamine study, 15-year follow-up, AEDG gene expression work, the vote breakdown.

For research use only. Not for human or veterinary consumption. This post is educational and is not medical advice.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord.

u/JustBacWater — 23 days ago

BPC-157, TB-500 and the FDA peptide panel: six passed, DSIP didn't, and what it changes

Okay, so a lot of you have been asking about the FDA panel from July, and there's a lot of bad info going around. I've seen people saying BPC-157 got approved. It didn't. Let me walk through what happened, because the real story is more interesting than the headline anyway.

Quick background. Back in February, HHS said a group of peptides was coming off Category 2. Category 2 is basically the do-not-touch list for compounding pharmacies. Then FDA scheduled a Pharmacy Compounding Advisory Committee meeting, PCAC, for July 23rd and 24th to vote on seven of them.

Here's how it went.

Peptide Yes No Abstain Result
BPC-157 8 6 1 Passed
TB-500 8 6 1 Passed
KPV 8 6 1 Passed
Semax 8 5 1 Passed
MOTS-c 7 5 2 Passed
Epitalon 7 4 1 Passed
DSIP 6 7 1 Failed

The part that got buried

FDA's own scientists recommended against all seven. Every one. Their reasons were pretty consistent: not enough human safety data, immunogenicity risk, impurities, and not enough characterization of what's in the material being made.

The panel went against its own staff on six out of seven.

And look at the margins. 8 to 6 isn't a landslide. That's a room split almost down the middle. Anybody telling you the science is settled because of this vote didn't look at the numbers.

What a yes gets you

Less than people think.

It's not approval. Category 1 means a compounding pharmacy can use it as a bulk ingredient. There's still no approved indication, no standardized dosing, and no established safety and efficacy.

It's not final. The vote is non-binding. FDA still has to go through notice-and-comment rulemaking, and realistically that's 12 to 24 months out.

It's 503A only. That's the individual prescription side. FDA has said basically nothing about 503B outsourcing facilities, which is the bigger volume side.

It doesn't touch research compounds. Different lane entirely. Nothing about this vote changes what a research compound is.

DSIP

DSIP was the only one that didn't make it, 6 to 7. It was up for insomnia, narcolepsy, and opioid withdrawal. I haven't seen a clean explanation of why it was DSIP and not one of the others, and I'm not going to make one up. If anybody watched that session, I want to hear what you caught.

What's next

FDA has a second meeting scheduled before February 2027 for the next group: GHK-Cu, Melanotan II, LL-37, Dihexa, and PEG-MGF.

That group is going to be a lot more interesting than this one. Melanotan II has a real dermatology signal on moles. LL-37 has the autoimmune side, it shows up in psoriasis and rosacea. PEG-MGF has no completed human trials at all. If this panel split 8 to 6 on BPC-157, that next meeting could go a lot of different ways.

Two questions for you.

The panel went against its own scientists on six out of seven. Good call, or a problem?

And which of the next five do you think makes it through?

Where I got this: the vote breakdown, how the process works, AJMC's summary.

For research use only. Not for human or veterinary consumption. This post is educational and is not medical advice.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord.

u/JustBacWater — 24 days ago

Vmount hot swap

When I try the hot swap, the fx6 goes black for a second when swapping even with a bpu battery fully charged. Is there a way for this to not happen. Rn the camera is powered vmount to DC

reddit.com
u/JustBacWater — 24 days ago

Peptides BPC-157 and TB-500: running them in separate vials instead of the Wolverine blend

The combined blend is where I started back in 2017, and it's what I kept in my research for years after. One vial, one injection, done. Cheaper, fewer syringes, less to think about.

I don't run it that way anymore, and the reason is dose control. Not purity, not a vendor thing, nothing exotic. The blend welds two compounds together that don't want the same schedule, and once I saw it I couldn't unsee it.

They do different jobs on different clocks

BPC-157 handles perfusion. It signals new capillary formation into tissue that isn't getting blood, and it calms inflammation without shutting it down. It's catalytic. Small amounts, every day, that's the model.

TB-500 handles logistics. It binds up G-actin so cells have a reserve pool ready to migrate, divide, and organize repair into real structure instead of scar tissue. Roads and traffic. They genuinely pair.

But TB-500 is mass-action, not catalytic. You need enough of it present at once to bind a meaningful chunk of available actin, which means big doses a couple times a week. That's not a preference, it's how the mechanism works. The literature is clear that bolus dosing a few times weekly outperforms smaller daily amounts.

Daily microdosing and twice-weekly bolus dosing aren't two styles of the same protocol. They're two different pharmacological models.

What the blend does to that

The blend locks both compounds onto BPC-157's schedule, because BPC-157 is the one that has to be daily. TB-500 just comes along for the ride at whatever fraction the fixed ratio gives it.

Which means TB-500 gets dripped out in small daily amounts instead of the bolus pattern it's built around. Even if you push the total up high enough that the weekly number looks fine, it's still arriving seven small times instead of two or three big ones. You can hit the number and completely miss the mechanism.

And here's the part that killed it for me: you can't fix it inside the blend. Turning the total up to get TB-500 where it should be pushes BPC-157 past where it should be at the same time. The ratio is welded in. There's no lever you can move by itself.

What separate vials get me

Each one runs on the schedule it was studied on. BPC-157 daily, near the target when I can get near it. TB-500 as a bolus a couple times a week. Two different compounds, two different clocks, which is what they were always supposed to be.

The other thing I get is a clean read. With a blend, whatever happens belongs to a fixed ratio I didn't pick. Separate vials mean I can move the TB-500 side without touching BPC-157, or run BPC-157 alone for a block to see what it does by itself. The protocol turns into something I can reason about instead of one unit that either works or doesn't.

Doses and reconstitution for both are in the pinned cheat sheet.

What it costs

Two vials instead of one. More syringes. Two reconstitutions to keep straight at different concentrations, so two sets of unit math and more room to screw it up if you're careless.

That's real and the blend exists for a reason. If the alternative is running nothing because the logistics are annoying, the blend beats nothing easily.

But it should be a choice you made on purpose. I spent years assuming the blend was the Wolverine stack. What it is is BPC-157 at a reasonable dose and TB-500 dripped out in a pattern its mechanism doesn't favor.

Couple things I had wrong for way too long

Injection site. I read BPC-157 as purely systemic for way too long. Local matters. Close to the target when the anatomy allows it, because you get higher first-pass concentration before it dilutes out. Abdominal is the fallback for stuff you can't reach, not the default.

NSAIDs alongside it. This is the one I wish somebody had pointed out to me early. NSAIDs and steroids suppress the same inflammatory signaling that drives collagen deposition, which is why they hurt repair quality even while they kill pain. BPC-157's whole mechanism is modulating that inflammation without shutting it off. Running an NSAID on top works directly against it.

Duration. Open-ended isn't a more aggressive protocol, it's a more expensive one. Defined blocks, then stop. No tolerance builds, but these protocols are self-limiting by design.

Regulatory note

Worth saying because it changed. FDA moved BPC-157 to Category 2 in 2023, so it can't be legally compounded. WADA prohibits it under class S0. DoD banned it for military. If you compete in a tested federation you need to know that.

Pentadeca Arginate showed up after the ruling. Same active sequence, different salt, better gastric stability, and zero PDA-specific peer-reviewed research. Every claim about it is borrowed from BPC-157 data. Might turn out fine. Borrowed evidence still isn't evidence.

Anybody put separate vials up against the blend and track a difference, or is the mass-action argument still theoretical out here?

And if the blend is what you're on: do you know what the weekly TB-500 total works out to? I didn't for years.

For research use only. Not for human or veterinary consumption. This post is educational and is not medical advice.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord.

reddit.com
u/JustBacWater — 30 days ago

Which peptide had the biggest gap between the hype and what the research actually shows?

Every compound has a reputation online, and some of them are running way ahead of what the data actually backs up. Others are the opposite, quietly well-supported but nobody talks about them.

So which one, in your reading, had the loudest hype but the thinnest research behind it when you actually dug in? And flip it, which one is better supported than its reputation suggests? The gap between what gets repeated and what the studies show is where most people get misled.

Curious if everyone lands on the same overhyped one, or if it's split.

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

Tesamorelin breakdown: the visceral fat peptide and how it's dosed

Tesamorelin has the strongest evidence in this space for one specific target, visceral fat, the deep fat stored around the organs. It's a GHRH analog, so it works upstream through the growth hormone axis, but what sets it apart is where the fat reduction lands in the research.

It's a stabilized version of GHRH that signals the pituitary to release growth hormone in a natural pulse. That GH increase drives lipolysis, and visceral fat carries more GH receptors than subcutaneous fat, so it responds harder. That's why the research shows it reducing visceral fat specifically, not just general body weight. It's also the one GH compound in this space that's FDA approved, for visceral fat in a specific patient group, so the evidence base is unusually solid here.

Dosing in the research runs daily:

  • Studied at 1 to 2mg daily
  • Administered at night, since that lines up with the natural GH pulse
  • Long courses, 12 weeks and up, since the change builds over months
  • Reconstitution, 2mL into the 10mg vial gives 5mg/mL

The honest catch is that the effect reverses on discontinuation. In the trials the visceral fat returned after the compound was stopped, so it shifts things during the run rather than resetting a new baseline. It's an ongoing intervention in the research, not a one-and-done.

Markers tracked are IGF-1, the anchor for any GH compound, plus glucose, since the GH axis can move blood sugar. The pattern watched for is IGF-1 climbing into range without overshooting.

Anyone whose research targeted visceral fat specifically, did that deep abdominal fat move, or did it read more like general GH effects?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

Does BPC-157 need to be injected near the injury to work?

This gets repeated as fact, that BPC has to go in right at the injury or it won't do anything, like it only repairs the exact spot it's administered. Half true, half myth, worth clearing up.

Here's the reality. BPC-157 works systemically. Once it's in circulation it travels through the whole body and acts wherever there's damage, it doesn't stay parked at the administration site. So it doesn't have to be placed at the exact target to have an effect. A subcutaneous dose in one area still reaches damaged tissue elsewhere.

Where the "near the site" idea has merit is local concentration. Placing it closer to the target gives that area a higher concentration before it dilutes into the rest of the body, so for something stubborn like a tendon, near the site isn't pointless. It's a small edge, not a requirement.

The takeaway, a dose placed away from the target isn't wasted, it still gets there through circulation. Closer placement is a minor optimization for tough local spots, not a make or break rule.

Who believed it only worked at the injection site? And has anyone in their research actually seen a difference between local placement and a general subQ site?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

Semax vs Selank: what each does and why they run together

These two get lumped together as the Russian nootropic peptides and treated like the same thing. They're not, they do opposite jobs, and that's exactly why they get paired.

Semax is the focus one. It bumps BDNF, the growth factor the brain uses to build and repair connections, so the research is around focus, clarity, and mental drive. It's mildly stimulating, so it's studied as a morning compound. Dose it late and it can push into your sleep.

Selank is the calm one. It's an anxiolytic, so it brings anxiety down, but not the benzo way. Instead of forcing GABA channels open and leaving you foggy and dependent, it supports your own inhibitory tone, so you get a lower anxiety floor without a lower cognitive ceiling. Russian trials ran it against a benzo and it matched the anxiety relief with none of the sedation.

Run together, the logic is simple. Semax pushes you forward and can leave you a little wired. Selank takes that edge off without dulling the focus. One brings the drive, the other smooths it, so you get clarity without the jitter.

Couple things they share. Neither hits like a stimulant, both build over a few days as gene expression shifts, so anyone waiting on a caffeine kick will think they're duds. Both lean on a solid Russian clinical record but no Western trials. And both come in nasal forms, which absorb well since they're small enough to cross intranasally.

If you run these, are you stacking them or riding one solo? Curious how the combo versus single shakes out.

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

How to read a peptide COA and spot a fake one

A COA is the one document that tells you what's actually in a vial, and fake ones are everywhere now, whether it's AI generated or just photoshopped. Here's how to read one and confirm it's real, because a screenshot on a product page means nothing on its own.

The step that catches almost everything is verifying it at the source. Don't trust the PDF you were handed, check it on the testing lab's own website. Most of the labs vendors use now, Janoshik, Freedom Diagnostic, ILS, and others, have a verification page where you enter the report or batch number and it pulls the real result straight from their system. If what you were handed doesn't match what the lab's own site shows, it's fake.

Once it's confirmed real, a legit COA has:

  • A report number and lab name you can actually look up
  • A batch number that matches the batch printed on the vial
  • A date, ideally within the last year
  • An HPLC chromatogram, the actual graph, with one clean dominant peak
  • The compound identity confirmed, usually by mass spec
  • A purity percentage, 95% is the floor, 98%+ is what you want

The chromatogram matters more than people realize. A number like "99%" typed on a page means nothing without the graph behind it showing one tall peak instead of a cluster of smaller ones, which would mean impurities.

Red flags are no batch number, no report number to verify, a purity figure with no chromatogram, the same single COA shown for every product they sell, or no lab name, just a logo. A COA is supposed to be per batch, not one trophy reused forever.

Last thing, even a verified COA only proves that batch was clean when tested. It doesn't prove the specific vial was stored right afterward. Strong signal, not a total guarantee, which is why matching the batch number to the vial is what ties it together.

Anyone run into a COA that looked clean but didn't verify when you actually checked the lab's site?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

Tirzepatide breakdown: how the dual agonist works and how it's dosed

Tirzepatide is one of the most run compounds in the whole space right now, and it's worth understanding why it hits differently than semaglutide. It's a dual agonist, and that second receptor is the whole story.

Semaglutide works on one receptor, GLP-1. Tirzepatide works on two, GLP-1 and GIP. Both cut appetite and improve blood sugar, but adding the GIP side gives it a stronger effect on weight and better handling of the nausea for a lot of people. That's why the trial numbers came in higher than semaglutide, around 22% body weight in the studies, and why it's the FDA-approved one people reach for.

The GLP-1 side does the appetite suppression and slows gastric emptying, so food sits longer and you eat less. The GIP side improves how the body handles insulin and fat, and it seems to take some of the edge off the GI side effects that come with GLP-1 alone. Two levers instead of one.

Dosing in the research runs as a slow titration:

  • Studied start around 2.5mg weekly, held for the first few weeks
  • Steps up over time, 5mg, then higher, spaced weeks apart
  • Studied range goes up to 15mg weekly
  • Reconstitution, 2mL into the 10mg vial gives 5mg/mL

The titration is the part people rush and regret. Stepping up too fast is what drives the nausea, and holding each dose a few weeks before climbing keeps it manageable. It has a long half-life, around 5 days, so a dose takes weeks to fully settle, which is why patience on the ramp matters.

Bloodwork worth tracking is glucose, HbA1c, and lipids, same as the GLP class. And muscle loss is the honest caveat with all of these, a chunk of the weight lost is lean tissue, so protein and resistance training are what protect it.

Anyone running tirz over sema, did the dual agonist actually feel different on appetite or sides, or about the same?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

help with irl content

I was using FX3 forever for IRL streaming for someone famous, and I have an FX6 that I've never used. And I thought maybe I can use this, but the only reason I never use it is because I don't know how to use this camera. Is not like the FX3. We move a lot from indoors to outdoors, to dark places to bright places, and I was wondering if the auto settings would be good enough. With the FX3, I don't have auto settings other than white balance. And not having an ND filter when going outside facing the bright sun, I have to crank the aperture. Drop the ISO a lot. I'm able to do it at a good speed to where it doesn't mess up the live stream. But I guess my question is, since the FX6 has the high/low ISO. Should I still use auto or use it manually?

reddit.com
u/JustBacWater — 1 month ago

new job 200 miles a day?

I got a new job, and it's 200 miles a day. The pay is amazing, so I can't really say no, but this is a lot of miles. Would my macan be okay to handle this oil changes be needed so often because of this. Or should I look into something just for this drive? They're currently letting me take the company car until I get my own car. And I also don't want to take the company car because that thing gets the worst miles per gallon.

reddit.com
u/JustBacWater — 1 month ago

Does GHK-Cu need to be daily or is 2-3x weekly enough?

This one splits the room every time. Some protocols run GHK-Cu daily, others say 2 to 3 times a week is plenty and daily is overkill. People state their side like it's settled. It isn't, and here's the honest picture.

There's no human trial on injectable GHK-Cu frequency. None. So both the daily crowd and the 2 to 3x weekly crowd are following conventions, not proven schedules. Neither can point to a study that ran the comparison.

The 2 to 3x weekly logic is the signaling-window idea. GHK-Cu is concentration dependent, meaning it behaves differently at different tissue levels, so the thinking is you pulse it and let the remodeling run in the days between doses, rather than holding it high constantly.

The daily logic is simpler. Topical GHK-Cu is used daily, and the healing blends that contain it run daily, so daily clearly gets used and isn't dangerous. More frequent just feels like it should do more.

So which is right? Neither is proven over the other. Daily at a moderate amount is common and fine. The 2 to 3x weekly is the more cautious, spaced-out approach. Both get run, and no study settles it. Anyone claiming one is the only correct way is stating a preference as a fact.

Where do you land, daily or spaced out, and did you ever notice a difference between the two?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

Does lyophilized peptide powder need to be refrigerated?

Short answer, no, and here’s why. Lyophilized just means freeze dried, and the whole point of freeze drying it is to make it shelf stable without cold. Dry powder handles room temp for weeks, and a warm mailbox for a couple days isn’t wrecking it. What makes peptides fragile is water, and there’s no water in it yet. A sealed powder vial sitting at room temp, or showing up warm from shipping, is almost always totally fine.

Cold does matter, just not where people think:

• Long term storage of the dry powder, if you’re sitting on it for months, the freezer buys you shelf life
• After you reconstitute it, now there’s water in there and it does need the fridge. That’s the real rule people are half remembering
• A few fragile ones like cold even as powder, but they’re the exception, not the default

The whole myth is just a timing mixup. Fridge and freezer matter for long storage and for after you mix. Not for a sealed powder vial that spent a day on your counter or showed up warm. People are tossing perfectly good vials over this and it drives me nuts.

Anyone here ever panic over a warm shipment or throw out a vial you didn’t actually need to?

Research and educational use only.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

The “never shake your vial” myth. Janoshik says you can. Who’s right

Everyone repeats it: never shake a peptide vial, only swirl, or you’ll destroy the peptide. It gets said like a hard rule. But Janoshik, one of the testing labs everyone quotes for purity, has openly said shaking doesn’t degrade peptides. So which is it.

Here’s the actual answer. The “shaking denatures peptides” idea got carried over from large, fragile proteins like antibodies, where shaking can cause problems. Most research peptides are short and stable and don’t degrade from the physical act of shaking. Janoshik has said they’ve tested this and shaking didn’t hurt potency. So on the peptide surviving, the lab wins that one.

Where the swirl advice still has a point is foaming. Shaking whips air in and creates foam and bubbles, which doesn’t wreck the peptide but makes it a pain to draw accurately and can mess with your measured dose. So the reason to swirl isn’t that shaking kills the peptide, it’s that foam makes dosing sloppy.

Bottom line: shaking won’t destroy your peptide, the lab settled that. Swirling is still the cleaner move because it keeps the solution bubble free and easier to draw. So the myth is half wrong, the “it degrades” part is false, the “swirl for a clean draw” habit is still fine.

So where do you land, were you a never shaker, and did you think it actually degraded the peptide or just knew to swirl without knowing why?

Research and educational use only.

reddit.com
u/JustBacWater — 1 month ago

How to read a COA and tell if it's fake

A COA is the one document that tells you what's actually in a vial, and fake ones are everywhere now, whether it's AI generated or just photoshopped. Here's how to actually read one and verify it's real, because a screenshot on a product page means nothing on its own.

Verify it at the source first

This is the step that catches almost everything. Don't trust the PDF you were handed, check it on the testing lab's own website. Most of the labs vendors have a verification page where you enter the report or batch number and it pulls the real result straight from their system. If the COA you got doesn't match what the lab's own site shows, it's fake. Simple as that.

What a real COA actually has

Once you've confirmed it's real, a legit one includes:

  • A report number and a lab name you can actually look up
  • A batch number that matches the batch printed on the vial
  • A date, ideally within the last year
  • An HPLC chromatogram, the actual graph, with one clean dominant peak
  • The compound identity confirmed, usually by mass spec
  • A purity percentage, 95% is the floor, 98%+ is what you want

The chromatogram matters more than people give it credit for. A number like "99%" typed on a page means nothing without the graph behind it showing one tall peak instead of a bunch of smaller ones, which would mean impurities.

Red flags

  • No batch number, or a batch that doesn't match the vial
  • No report number to verify anywhere
  • A purity figure with no chromatogram behind it
  • The same single COA shown for every product and every batch they've ever sold
  • No lab name, just a logo

That fourth one is big. A COA is supposed to be per batch. A vendor flashing one report from two years ago for everything they sell isn't testing every batch, they're showing a trophy.

The part even a real COA doesn't cover

A verified COA proves that batch was clean when it was tested. It doesn't prove the specific vial was stored and handled right afterward, or that what shipped is from that exact batch. It's the strongest signal you've got, but not a total guarantee, which is why matching the batch number to the vial is what ties it all together.

Verify on the lab's site, match the batch to the vial, and look for the chromatogram, not just a number. That covers most of it.

Anyone run into a COA that looked clean but didn't verify when you actually checked the lab's site? Curious how common the fakes are getting.

Full doses and bloodwork are in the pinned cheat sheet.

Join the Discord

reddit.com
u/JustBacWater — 1 month ago

We've got a Discord now, come hang

We finally set up a Discord for the community. Same research-first vibe as the sub, just faster and easier to actually talk.

What it's good for:

  • Quick questions that don't need a whole post
  • Compound and protocol talk in real time
  • Bloodwork, reconstitution, and COA help
  • Vendor and testing discussion
  • Early looks at guides and cheat sheet updates

Same rules as here, research and educational only. No sourcing, no human-use posting.

It's free, come through.

Join the Discord

Full doses and bloodwork are in the pinned cheat sheet.

reddit.com
u/JustBacWater — 2 months ago